Fineotex Chemical Limited (BOM:533333)
24.09
+0.16 (0.67%)
At close: Feb 13, 2026
Fineotex Chemical Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 5,783 | 5,333 | 5,690 | 5,170 | 3,682 | 2,185 |
Other Revenue | 68.52 | - | - | 1.29 | - | 11.72 |
Revenue | 5,851 | 5,333 | 5,690 | 5,171 | 3,682 | 2,197 |
Revenue Growth (YoY) | 3.28% | -6.26% | 10.03% | 40.43% | 67.62% | 11.89% |
Cost of Revenue | 3,722 | 3,286 | 3,516 | 3,418 | 2,370 | 1,418 |
Gross Profit | 2,129 | 2,047 | 2,173 | 1,753 | 1,312 | 779.16 |
Selling, General & Admin | 341.32 | 289.22 | 250.78 | 214.79 | 160.88 | 105.32 |
Other Operating Expenses | 588.35 | 478.38 | 436.83 | 407.53 | 432.4 | 249.79 |
Operating Expenses | 1,040 | 859.81 | 747.81 | 665.11 | 618.41 | 369.86 |
Operating Income | 1,089 | 1,187 | 1,426 | 1,088 | 693.87 | 409.3 |
Interest Expense | -3.1 | -2.42 | -3.45 | -2.08 | -2.78 | -1.83 |
Interest & Investment Income | 31.31 | 31.31 | 19.68 | 10.53 | 9.74 | 16.33 |
Currency Exchange Gain (Loss) | 10.58 | 10.58 | 11.79 | 18.12 | 4.97 | -1.61 |
Other Non Operating Income (Expenses) | -5 | -5.01 | -6.23 | 33.04 | 27.08 | 136.44 |
EBT Excluding Unusual Items | 1,123 | 1,222 | 1,447 | 1,148 | 732.87 | 558.64 |
Gain (Loss) on Sale of Investments | 190.65 | 190.65 | 128.26 | - | 0.01 | - |
Pretax Income | 1,313 | 1,412 | 1,576 | 1,148 | 732.88 | 558.64 |
Income Tax Expense | 299.8 | 320.35 | 365.42 | 252.44 | 163.98 | 113.08 |
Earnings From Continuing Operations | 1,014 | 1,092 | 1,210 | 895.55 | 568.9 | 445.56 |
Minority Interest in Earnings | -42.39 | -10 | -12.16 | -12.39 | -17.15 | -19.69 |
Net Income | 971.13 | 1,082 | 1,198 | 883.16 | 551.74 | 425.88 |
Net Income to Common | 971.13 | 1,082 | 1,198 | 883.16 | 551.74 | 425.88 |
Net Income Growth | -17.94% | -9.68% | 35.66% | 60.07% | 29.55% | 225.69% |
Shares Outstanding (Basic) | 1,103 | 1,136 | 1,108 | 1,107 | 1,107 | 1,110 |
Shares Outstanding (Diluted) | 1,103 | 1,136 | 1,108 | 1,107 | 1,107 | 1,110 |
Shares Change (YoY) | -2.28% | 2.56% | 0.00% | - | -0.20% | -0.30% |
EPS (Basic) | 0.88 | 0.95 | 1.08 | 0.80 | 0.50 | 0.38 |
EPS (Diluted) | 0.88 | 0.95 | 1.08 | 0.80 | 0.50 | 0.38 |
EPS Growth | -16.02% | -11.93% | 35.65% | 60.07% | 29.82% | 226.66% |
Free Cash Flow | - | -73.46 | 495 | 878.37 | -91.37 | -150.11 |
Free Cash Flow Per Share | - | -0.07 | 0.45 | 0.79 | -0.08 | -0.14 |
Dividend Per Share | 0.040 | 0.080 | 0.160 | 0.080 | 0.040 | 0.030 |
Dividend Growth | -50.00% | -50.00% | 100.00% | 100.00% | 33.33% | 500.00% |
Gross Margin | 36.38% | 38.38% | 38.20% | 33.91% | 35.64% | 35.47% |
Operating Margin | 18.61% | 22.26% | 25.06% | 21.05% | 18.84% | 18.63% |
Profit Margin | 16.60% | 20.29% | 21.06% | 17.08% | 14.98% | 19.39% |
Free Cash Flow Margin | - | -1.38% | 8.70% | 16.99% | -2.48% | -6.83% |
EBITDA | 1,205 | 1,280 | 1,486 | 1,131 | 719 | 424.05 |
EBITDA Margin | 20.59% | 23.99% | 26.11% | 21.87% | 19.53% | 19.30% |
D&A For EBITDA | 116.21 | 92.21 | 60.2 | 42.8 | 25.13 | 14.75 |
EBIT | 1,089 | 1,187 | 1,426 | 1,088 | 693.87 | 409.3 |
EBIT Margin | 18.61% | 22.26% | 25.06% | 21.05% | 18.84% | 18.63% |
Effective Tax Rate | 22.83% | 22.68% | 23.19% | 21.99% | 22.38% | 20.24% |
Revenue as Reported | 6,094 | 5,576 | 5,855 | 5,243 | 3,737 | 2,360 |
Advertising Expenses | - | 11.6 | 6.17 | 2.77 | 3.83 | 2.46 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.